| |
| Funding |
| |
| Current Grants |
|
Muscular Dystrophy Association of America (MDA). Antigen-specific therapeutic autoantibody depletion in myasthenia gravis (MDA158763). 2010-2012.
Association Francaises des Myopathies (AFM), Pentameric AChR extracellular domain for efficient autoantibody depletion in myasthenia gravis. 2009-2011
EC. Public Health. European Myasthenia Gravis Network (EuroMyasthenia). 2006-2009.
FP6. STREP. Development of models to improve management of myasthenia gravis: From basic knowledge to clinical application (Myastaid). 2006-2010
FP7. Neurotransmitter Cys-loop receptors: structure, function and disease (Neurocypres). 2008-20012
FP7. Myasthenias, a group of immune mediated neurological diseases: from etiology to therapy (Fight-MG). |
|
|
|
|